Related Experiment Video
Updated: Feb 17, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Identity crisis in pulmonary arterial hypertension
G Ruffenach1, S Bonnet1, S Rousseaux2
11 Groupe de recherche en hypertension pulmonaire et biologie vasculaire, 55973 Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, QC, Canada.
Pulmonary arterial hypertension (PAH) mirrors cancer's "identity crisis" by abnormally expressing genes typically silenced in specific tissues. This finding reveals a shared molecular mechanism between these distinct diseases.
Area of Science:
- Molecular Biology
- Oncology
- Pulmonary Medicine
Background:
- Pulmonary arterial hypertension (PAH) exhibits similarities to cancer.
- Cancer progression is driven by a process termed "identity crisis," involving pathological Darwinian evolution.
- This crisis in cancer involves the aberrant expression of genes normally silenced in specific tissues.
Purpose of the Study:
- To investigate if pulmonary arterial hypertension (PAH) shares the cancer cell "identity crisis" hallmark.
- To determine if ectopic gene expression is a shared feature between PAH and cancer.
Main Methods:
- Comparative analysis of gene expression profiles in PAH and cancer.
- Identification of normally silent tissue-specific genes.
- Assessment of ectopic gene expression in PAH pathogenesis.
Main Results:
- Pulmonary arterial hypertension (PAH) demonstrates significant overlap with cancer hallmarks.
- The study identified ectopic expression of normally silent tissue-specific genes as a key shared feature.
- This ectopic gene expression is a striking characteristic of the cancer "identity crisis" also present in PAH.
Conclusions:
- Pulmonary arterial hypertension (PAH) shares critical molecular mechanisms with cancer, specifically the "identity crisis" characterized by ectopic gene expression.
- This finding suggests a potential for novel therapeutic strategies targeting shared pathways.
- Further research into these shared mechanisms could illuminate both PAH and cancer biology.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Pulmonary Embolism I: Introduction
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

